Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan (vol 43, pg 842, 2008)

被引：0
|
作者：
Suenaga, Mitsukuni [1 ]
Mizunuma, Nobuyuki [1 ]
Shouji, Daigo [1 ]
Shinozaki, Eiji [1 ]
Matsusaka, Satoshi [1 ]
Chin, Keisho [1 ]
Oya, Masatoshi [2 ]
Yamaguchi, Toshiharu [2 ]
Muto, Tetsuichiro [2 ]
Hatake, Kiyohiko [1 ]
机构：
[1] Canc Inst Hosp, Dept Med Oncol, Japanese Fdn Canc Res, Koto Ku, Tokyo 1358550, Japan
[2] Canc Inst Hosp, Div Gastroenterol Surg, Japanese Fdn Canc Res, Tokyo 1358550, Japan
来源：
JOURNAL OF GASTROENTEROLOGY | 2009年 / 44卷 / 07期
关键词：
D O I：
10.1007/s00535-009-0079-x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：801 / 801
页数：1
相关论文
共 50 条
  • [31] Oral doxifluridine plus leucovorin in metastatic colorectal cancer - Randomized phase II trial with intravenous 5-fluorouracil plus leucovorin
    Ahn, JH
    Kim, TW
    Lee, JH
    Min, YJ
    Kim, JG
    Kim, JC
    Yu, CS
    Kim, WK
    Kang, YK
    Lee, JS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01): : 98 - 102
  • [32] Irinotecan combined with bolus 5-fluorouracil and folinic acid for metastatic colorectal cancer: Is this really a dangerous treatment?
    Idelevich, E
    Man, S
    Lavrenkov, K
    Gluzman, A
    Geffen, DB
    Shani, A
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (05) : 487 - 490
  • [33] Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer
    Yalcin, S
    Oksuzoglu, B
    Tekuzman, G
    Engin, H
    Celik, I
    Turker, A
    Barista, I
    Gullu, I
    Guler, N
    Altundag, K
    Ozisik, Y
    Kars, A
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 580 - 583
  • [34] 5-FLUOROURACIL, LEUCOVORIN AND IRINOTECAN (FOLFIRI) PLUS BEVACIZUMAB (BV) IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): A MULTICENTER PHASE II TRIAL
    Cordio, S.
    Parra, Soto H. J.
    Pumo, V
    Condorelli, S.
    Latteri, F.
    Sambataro, D.
    Rosati, G.
    Aprile, G.
    Fassari, G.
    De Pauli, F.
    Rimassa, L.
    Bordonaro, R.
    ANNALS OF ONCOLOGY, 2009, 20
  • [35] Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study
    Deng, Ting
    Zhang, Le
    Liu, Xiao-jian
    Xu, Jian-ming
    Bai, Yu-xian
    Wang, Yan
    Han, Yu
    Li, Yu-hong
    Ba, Yi
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [36] Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study
    Ting Deng
    Le Zhang
    Xiao-jian Liu
    Jian-ming Xu
    Yu-xian Bai
    Yan Wang
    Yu Han
    Yu-hong Li
    Yi Ba
    Medical Oncology, 2013, 30
  • [37] First line polichemotherapy (PCT) with irinotecan plus leucovorin plus 5-fluorouracil (FOLFIRI) and bevacizumab in patients (Pts) with metastatic colorectal cancer (MCRC): A phase II study in our institution
    Roda, G.
    Nonnis, D. Carta A.
    Galmozzi, A.
    Nastasi, G.
    Cotroneo, G.
    ANNALS OF ONCOLOGY, 2007, 18 : 8 - 8
  • [38] Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel in gastric cancer with severe peritoneal metastasis (JCOG1108/WJOG7312G).
    Yamaguchi, Kensei
    Nakajima, Takako Eguchi
    Boku, Narikazu
    Hyodo, Ichinosuke
    Mizusawa, Junki
    Hara, Hiroki
    Nishina, Tomohiro
    Sakamoto, Takeshi
    Shitara, Kohei
    Shinozaki, Katsunori
    Katayama, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [39] Efficacy of bevacizumab plus bolus irinotecan, fluorouracil and leucovorin (IFL-BV) for highly pretreated metastatic colorectal cancer (MCRC)
    Carrera, S.
    Munoz, A.
    Gil-Negrete, A.
    Rubio, I
    Ancizar, N.
    Calvo, B.
    Fuente, N.
    Barcelo, R.
    Janhi, M.
    Lopez-Vivanco, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 68 - 68
  • [40] Posterior Reversible Encephalopathy Syndrome During Treatment with Aflibercept, 5-Fluorouracil, Leucovorin, and Irinotecan for Metastatic Colorectal Cancer
    Miaris, Nikolaos
    Sgouros, Joseph
    Gerolympou, Margarita
    Spyropoulos, Basilios
    Drakopoulos, Dionysios
    Gkoura, Stefania
    Res, Helen
    Samantas, Epaminondas
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (01) : 123 - 126
12345